Advertisement
Organisation › Details
Johns Hopkins Center for Alternatives to Animal Testing (CAAT)
The Johns Hopkins Center for Alternatives to Animal Testing (CAAT) has worked with scientists since 1981 to find new methods to replace the use of laboratory animals in experiments, reduce the number of animals tested, and refine necessary tests to eliminate pain and distress. CAAT is an academic, science-based center affiliated with the Johns Hopkins University Bloomberg School of Public Health. It is based on the belief that the best science is humane science. The programs seek to provide a better, safer, more humane future for people and animals. CAAT provides a variety of resources, including grants for scientists developing non-animal methods, workshops on alternative methods, books, newsletters, and other publications. CAAT also manages Altweb, an international online clearinghouse of alternatives news and resources. CAAT's approach to toxicology follows the 3Rs principle to pursue alternative toxicological methods that reduce, refine and replace the use of laboratory animals in toxicological research. The principle of the 3Rs was first proposed by William Russell and Rex Burch in 1959. In their book "The Principles of Humane Experimental Technique," they classified humane techniques under the headings refinement, reduction, and replacement, commonly known now as the 3Rs. *
![]() |
Start | 1981-01-01 established |
| Group | Johns Hopkins University | |
![]() |
Industry | toxicology |
![]() |
Person | Hartung, Thomas (Johns Hopkins Univ 201008 Director CAAT) |
![]() |
Region | Baltimore, MD |
| Country | United States (USA) | |
| City | n. a. Baltimore, MD | |
| Address record changed: 2011-05-15 | ||
| Basic data | Employees | n. a. |
| * Document for »About Section«: Agilent Technologies Inc.. (8/18/10). "Press Release: Agilent Technologies and Johns Hopkins University to Research Novel Toxicity Pathways for Embryonic Brain Development Using Metabolomics". Santa Clara, CA & Baltimore, MD. | ||
Record changed: 2011-11-25 |
More documents for Johns Hopkins University
- [1] Agilent Technologies Inc.. (8/18/10). "Press Release: Agilent Technologies and Johns Hopkins University to Research Novel Toxicity Pathways for Embryonic Brain Development Using Metabolomics". Santa Clara, CA & Baltimore, MD....
- [2] Protea Biosciences, Inc.. (7/21/09). "Press Release: Protea Anounces Exclusive License Agreement with Johns Hopkins University. Collaboration Will Focus on the Development of New Protein Tests for Cardiovascular Disease". Morgantown, WV....
- [3] Shimadzu Biotech. (5/29/06). "Press Release: Shimadzu Biotech Enhances Bio-research Analyses with new Axima-TOF². High-energy MALDI CID MS/MS Instrumentation Delivers Greater Sensitivity Flexibility". Columbia, MD....
- [4] Expression Pathology Inc.. (9/28/04). "Press Release: EPI Awarded SBIR Grant to Develop Prostate Cancer Liquid Tissue Arrays". Gaithersburg, MD....
- [5] Shimadzu Biotech. (6/01). "Press Release: Mass Correlated Acceleration to Revolutionize Life Science Research. Shimadzu Biotech Licenses Unique Technology from Johns Hopkins"....
To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com
» top
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectrometry-portal-logo.jpg)









![Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)